Summary

● The company has poor fundamentals for a short-term investment strategy.


Strengths

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● The stock is in a well-established, long-term rising trend above the technical support level at 38.05 EUR


Weaknesses

● Stock prices approach a strong long-term resistance in weekly data at EUR 70.

● The stock is close to a major daily resistance at EUR 70, which should be gotten rid of so as to gain new appreciation potential.

● Low profitability weakens the company.

● The company is in debt and has limited leeway for investment

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 50.86 times its estimated earnings per share for the ongoing year.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.

● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.